Vaccine composition containing synthetic adjuvant

US20200376116A1 · office US · priority 2006-09-26 · published 2020-12-03

Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially …

Inventor: Steven G. Reed · Assignee: Infectious Disease Research Institute

Open the patent document · source query “malaria vaccine”